Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method

Information

  • Patent Grant
  • 10945832
  • Patent Number
    10,945,832
  • Date Filed
    Tuesday, April 30, 2019
    5 years ago
  • Date Issued
    Tuesday, March 16, 2021
    3 years ago
  • Inventors
  • Original Assignees
    • OnPoint Vision, Inc. (Aliso Viejo, CA, US)
  • Examiners
    • Willse; David H
    • Blanco; Javier G
Abstract
An apparatus includes an intraocular pseudophakic contact lens having an optical lens and haptics extending radially from the optical lens. The optical lens is configured to at least partially correct a residual refractive error in an eye. The residual refractive error includes a refractive error that exists in the eye after implantation of an artificial intraocular lens in the eye. The haptics are configured to be inserted under an anterior leaflet of a capsular wall in the eye in order to capture and confine the haptics under the anterior leaflet and secure the intraocular pseudophakic contact lens against the artificial intraocular lens. Anterior surfaces of the haptics are configured to contact an inner capsular wall surface at the anterior leaflet. Posterior surfaces of the haptics include ridges configured to capture at least one edge of the artificial intraocular lens in order to secure the intraocular pseudophakic contact lens to the artificial intraocular lens.
Description
TECHNICAL FIELD

This disclosure relates generally to implantable optical devices. More specifically, this disclosure relates to an intraocular pseudophakic contact lens with a mechanism for securing by an anterior leaflet of a capsular wall and a related system and method.


BACKGROUND

In a normal human eye, light enters through the cornea and passes through the pupil, and the natural crystalline lens focuses the light onto the retina of the eye. However, due to cataracts or other problems, the natural crystalline lens of an eye may need to be replaced with an artificial intraocular lens (IOL). The term “pseudophakia” is used to describe an eye in which the natural crystalline lens has been replaced with an intraocular lens.


Before an intraocular lens is placed into a patient's eye, a doctor or other personnel typically selects an intraocular lens that is designed to provide desired refractive correction for the patient's eye. For example, an intraocular lens could have an optical lens designed to correct myopia (near-sightedness), hyperopia (far-sightedness), astigmatism, or other refractive errors that occur naturally in the patient's eye. However, it is often the case that the intraocular lens selected for a patient's eye does not fully correct (and may even cause) some form of refractive error in the patient's eye. This refractive error is referred to as “residual” refractive error.


There are various conventional options for correcting residual refractive error, all of which have their disadvantages. For example, one intraocular lens in a patient's eye could be replaced with a different intraocular lens, but this typically has a high risk of surgical complications. Ablation surgery (such as LASIK) on the cornea of a patient's eye could be done to correct residual refractive error, but this can have a high level of unwanted side effects, particularly for older patients. An additional intraocular lens (often referred to as a “piggyback” IOL) could be inserted in front of an existing intraocular lens, but this is typically an invasive procedure with less predictability associated with the final refractive outcome. In addition, intracorneal lenses (ICLs) can be inserted into the cornea of a patient's eye, but this is often more invasive and has a high degree of rejection. In general, the above procedures are typically not predictable and have a higher degree of surgical risk. Also, the devices used in the above procedures are difficult to remove and “reverse” any residual refractive error, resulting in a higher risk of leaving the patient with induced visual aberration.


SUMMARY

This disclosure provides an intraocular pseudophakic contact lens with a mechanism for securing by an anterior leaflet of a capsular wall and a related system and method.


In a first embodiment, an apparatus includes an intraocular pseudophakic contact lens having an optical lens and haptics extending radially from the optical lens. The optical lens is configured to at least partially correct a residual refractive error in an eye, where the residual refractive error includes a refractive error that exists in the eye after implantation of an artificial intraocular lens in the eye. The haptics are configured to be inserted under an anterior leaflet of a capsular wall in the eye in order to capture and confine the haptics under the anterior leaflet and secure the intraocular pseudophakic contact lens against the artificial intraocular lens. Anterior surfaces of the haptics are configured to contact an inner capsular wall surface at the anterior leaflet. Posterior surfaces of the haptics include ridges configured to capture at least one edge of the artificial intraocular lens in order to secure the intraocular pseudophakic contact lens to the artificial intraocular lens.


In a second embodiment, a system includes an artificial intraocular lens and an intraocular pseudophakic contact lens. The artificial intraocular lens includes a first optical lens and first haptics configured to be implanted within a capsular bag in an eye. The intraocular pseudophakic contact lens includes a second optical lens and second haptics extending radially from the second optical lens. The second optical lens is configured to at least partially correct a residual refractive error in the eye, where the residual refractive error includes a refractive error that exists in the eye after implantation of the artificial intraocular lens in the eye. The second haptics are configured to be inserted under an anterior leaflet of a capsular wall in the eye in order to capture and confine the second haptics under the anterior leaflet and secure the intraocular pseudophakic contact lens against the artificial intraocular lens. Anterior surfaces of the second haptics are configured to contact an inner capsular wall surface at the anterior leaflet. Posterior surfaces of the second haptics include ridges configured to capture at least one edge of the artificial intraocular lens in order to secure the intraocular pseudophakic contact lens to the artificial intraocular lens.


In a third embodiment, an apparatus includes an intraocular pseudophakic contact lens having an optical lens and at least three haptics extending radially from the optical lens. The optical lens is configured to at least partially correct a residual refractive error in an eye, where the residual refractive error includes a refractive error that exists in the eye after implantation of an artificial intraocular lens in the eye. The haptics are configured to be inserted under an anterior leaflet of a capsular wall in the eye in order to capture and confine the haptics under the anterior leaflet and secure the intraocular pseudophakic contact lens against the artificial intraocular lens. Anterior surfaces of the haptics are configured to contact an inner capsular wall surface at the anterior leaflet. Posterior surfaces of the haptics include ridges configured to capture at least one edge of the artificial intraocular lens in order to secure the intraocular pseudophakic contact lens to the artificial intraocular lens. The optical lens is positioned above the anterior and posterior surfaces of the haptics such that the anterior and posterior surfaces of the haptics are positioned below at least part of a posterior surface of the optical lens. Each of the haptics includes an inner portion and an outer portion, where the inner portion of each haptic couples the optical lens and the outer portion of the haptic and the inner portion of each haptic projects outward and downward from the optical lens. For each haptic, the ridge is defined where the larger thickness of the outer portion of the haptic meets a smaller thickness of the inner portion of the haptic.


Other technical features may be readily apparent to one skilled in the art from the following figures, descriptions, and claims.





BRIEF DESCRIPTION OF THE DRAWINGS

For a more complete understanding of this disclosure and its features, reference is now made to the following description, taken in conjunction with the accompanying drawings, in which:



FIGS. 1 through 3 illustrate a first example intraocular pseudophakic contact lens according to this disclosure;



FIGS. 4 and 5 illustrate a second example intraocular pseudophakic contact lens according to this disclosure;



FIGS. 6 through 8 illustrate a third example intraocular pseudophakic contact lens according to this disclosure;



FIGS. 9 and 10 illustrate a fourth example intraocular pseudophakic contact lens according to this disclosure;



FIGS. 11 and 12 illustrate a fifth example intraocular pseudophakic contact lens according to this disclosure;



FIG. 13 illustrates a sixth example intraocular pseudophakic contact lens according to this disclosure;



FIGS. 14 and 15 illustrate a seventh example intraocular pseudophakic contact lens according to this disclosure;



FIGS. 16 through 18 illustrate an eighth example intraocular pseudophakic contact lens according to this disclosure;



FIGS. 19 through 21 illustrate a ninth example intraocular pseudophakic contact lens according to this disclosure;



FIGS. 22 through 24 illustrate a tenth example intraocular pseudophakic contact lens according to this disclosure;



FIGS. 25 through 27 illustrate an eleventh example intraocular pseudophakic contact lens according to this disclosure;



FIG. 28 illustrates an example intraocular lens and an example intraocular pseudophakic contact lens in a patient's eye according to this disclosure; and



FIG. 29 illustrates an example method for using an intraocular pseudophakic contact lens with an intraocular lens according to this disclosure.





DETAILED DESCRIPTION


FIGS. 1 through 29, discussed below, and the various embodiments used to describe the principles of the present invention in this patent document are by way of illustration only and should not be construed in any way to limit the scope of the invention. Those skilled in the art will understand that the principles of the invention may be implemented in any type of suitably arranged device or system.


This disclosure provides various intraocular pseudophakic contact lenses (IOPCLs) that can be used in conjunction with intraocular lenses (IOLs). An intraocular pseudophakic contact lens generally represents a contact lens-type device that can be implanted within a patient's eye and placed on the anterior surface of an intraocular lens in the patient's eye. The intraocular pseudophakic contact lens substantially corrects residual refractive error present after implantation of the intraocular lens, such as after a lensectomy (cataract) procedure. In addition, the intraocular pseudophakic contact lens includes haptics or other mechanisms allowing the intraocular pseudophakic contact lens to be confined/captured by the anterior leaflet of the capsular wall in the patient's eye. In some instances, the haptics or other mechanisms can actually attach to the anterior leaflet of the capsular wall, such as through fibrosis during the healing process, to help to secure the intraocular pseudophakic contact lens in place.


Unlike conventional approaches, an intraocular pseudophakic contact lens can be implanted with less surgical risk. Moreover, an intraocular pseudophakic contact lens allows a patient to see immediately after implantation of the intraocular pseudophakic contact lens. Further, an intraocular pseudophakic contact lens can be easily replaced if a different lens is needed to correct residual refractive error or even removed if necessary. In addition, with techniques such as intraoperative wavefront aberrometry now available, refractive outcome can be measured during the actual procedure in which an intraocular pseudophakic contact lens is being implanted, which helps to identify immediately that a desired refractive target is obtained.



FIGS. 1 through 3 illustrate a first example intraocular pseudophakic contact lens 100 according to this disclosure. In particular, FIG. 1 illustrates an oblique view of the intraocular pseudophakic contact lens 100, FIG. 2 illustrates a top view of the intraocular pseudophakic contact lens 100, and FIG. 3 illustrates a side view of the intraocular pseudophakic contact lens 100.


As shown in FIGS. 1 through 3, the intraocular pseudophakic contact lens 100 includes an optical lens 102. The optical lens 102 denotes the portion of the intraocular pseudophakic contact lens 100 that alters light passing through the intraocular pseudophakic contact lens 100. The light that passes through the optical lens 102 then travels through an associated intraocular lens before reaching the retina of a patient's eye.


The optical lens 102 can be formed from any suitable material(s), such as silicone or acrylic. The optical lens 102 can also be formed in any suitable manner, such as by using a mold or lathe cut manufacturing process. Different lenses 102 can be designed and manufactured to provide a wide range of diopters, and each optical lens 102 can be designed to correct any suitable refractive error(s). Example types of refractive errors that can be corrected include myopia, hyperopia, and astigmatism.


The optical lens 102 in this example has a convex top surface and a concave bottom surface. However, the optical lens 102 can have any other suitable shape, which could depend (at least in part) on the type of refractive error(s) being corrected. As particular examples, the optical lens 102 could be convex, concave, spherical, aspherical, toric, mono-focal, or multi-focal. The specific lens platform used as the optical lens 102 in the intraocular pseudophakic contact lens 100 can be selected to provide the desired refractive correction in a patient's eye. The optical lens 102 could also include various other features as needed or desired, such as when the optical lens 102 is weighted (like at its bottom) so that the optical lens 102 orients itself on an intraocular lens in a desired orientation (like for toric platforms) or when the optical lens 102 is tinted, is photochromic, or includes an ultraviolet (UV) absorber.


Multiple haptics 104a-104b extend from multiple sides of the optical lens 102. The haptics 104a-104b are sized and shaped so that they extend a short distance from the optical lens 102 and fit under the anterior leaflet of the capsular wall in a patient's eye after implantation. Each haptic 104a-104b could be formed from any suitable material(s) and in any suitable manner. For example, each haptic 104a-104b could be formed from the same material(s) as the optical lens 102. Note that while two haptics 104a-104b are shown here, the intraocular pseudophakic contact lens 100 could include any number of haptics, including a single haptic. Also note that while the haptics 104a-104b angle downward, the haptics 104a-104b could have any other suitable arrangement.


In this example, the haptics 104a-104b are separated from the optical lens 102 by projections or extensions 106 that project from the sides of the optical lens 102. These extensions 106 represents portions of the intraocular pseudophakic contact lens 100 in which ends of the haptics 104a-104b could be embedded. Each extension 106 could be formed from any suitable material(s) and in any suitable manner. For example, each extension 106 could represent a portion of the material(s) forming the optical lens 102 and therefore represent an extension of the optical lens 102 itself. However, this need not be the case. For instance, the optical lens 102 could be placed within a retaining ring that is integral with or attached to the extensions 106, or the extensions 106 could be secured to the optical lens 102 itself using adhesive or other suitable connecting mechanism.


Note that while two extensions 106 are shown here, the intraocular pseudophakic contact lens 100 could include any number of extensions, including a single extension. Also note that the presence of the extensions 106 is not required and that the haptics 104a-104b could be integrated directly with the optical lens 102. In those embodiments, the haptics 104a-104b could represent portions of the material(s) forming the optical lens 102, although this need not be the case. For instance, the optical lens 102 could be placed within a retaining ring that is integral with or attached to the haptics 104a-104b, or the haptics 104a-104b could be secured to the optical lens 102 itself using adhesive or other suitable connecting mechanism.


Each of the haptics 104a-104b includes a textured surface 108, which in this example is formed using various holes formed partially or completely through the haptics 104a-104b. The textured surfaces 108 allow the haptics 104a-104b to be captured and confined by the anterior leaflet of the capsular wall in a patient's pseudophakic eye. In some cases, the textured surfaces 108 allow the haptics 104a-104b to actually physically bond to the anterior leaflet of the capsular wall in the patient's eye, such as through fibrosis during the healing process. The haptics 104a-104b help to secure the intraocular pseudophakic contact lens 100 in place on an intraocular lens. Note that the numbers and sizes of the holes in the textured surfaces 108 are for illustration only and that the haptics 104a-104b could include different numbers and sizes of holes. For instance, the haptics 104a-104b could include a large number of very small holes or other structures forming a texture that promotes confinement, capture, or attachment to the anterior leaflet of the capsular wall.


The anterior leaflet of the capsular wall in a patient's eye is typically created during a capsulotomy in which the natural crystalline lens in the patient's eye is removed and replaced with an intraocular lens. The anterior leaflet represents the outer portion of the front side of the capsular bag that remains after an opening (referred to as a capsulorhexis) is formed in the capsular bag so that the natural crystalline lens can be removed. In some cases, this could occur long before the intraocular pseudophakic contact lens 100 is to be implanted. After the capsulotomy, the anterior leaflet of the capsular wall typically shrinks and undergoes fibrosis during the healing process.


When the intraocular pseudophakic contact lens 100 is inserted into the patient's eye, the intraocular pseudophakic contact lens 100 can be positioned so that the haptics 104a-104b extend under the anterior leaflet in the patient's eye. This allows the haptics 104a-104b to be captured and confined by the anterior leaflet. The haptics 104a-104b could also be physically attached to the anterior leaflet over time, such as by way of a “re-fibrosis” of the anterior leaflet. This re-fibrosis of tissue will bond to and cover part or all of the haptics 104a-104b, further securing the intraocular pseudophakic contact lens 100 in place. Note, however, that the intraocular pseudophakic contact lens 100 could also be implanted during the same procedure in which the intraocular lens is being implanted. In that case, the intraocular pseudophakic contact lens 100 could be secured by the haptics 104a-104b and possibly during fibrosis (and not re-fibrosis) within the patient's eye.



FIGS. 4 and 5 illustrate a second example intraocular pseudophakic contact lens 400 according to this disclosure. In particular, FIG. 4 illustrates an oblique view of the intraocular pseudophakic contact lens 400, and FIG. 5 illustrates a side view of the intraocular pseudophakic contact lens 400.


As shown in FIGS. 4 and 5, the intraocular pseudophakic contact lens 400 has various components that are the same as or similar to those forming the intraocular pseudophakic contact lens 100. For example, the intraocular pseudophakic contact lens 400 includes an optical lens 402, multiple haptics 404a-404b, and optionally multiple extensions 406. The haptics 404a-404b include textured surfaces 408.


The intraocular pseudophakic contact lens 400 also includes one or more pins 410. Each pin 410 projects downward from an extension 406 or from the inner end of a haptic 404a-404b. The pin(s) 410 can be used to pierce the anterior surface of an intraocular lens or to rest on the anterior surface of the intraocular lens. In addition to the capture/confinement of the haptics 404a-404b by the anterior leaflet, the pins 410 can help to further hold the intraocular pseudophakic contact lens 400 in place and resist slipping of the intraocular pseudophakic contact lens 400. In some cases, the pins 410 could be used to prevent movement of the intraocular pseudophakic contact lens 400 during the period immediately after implantation and before the haptics 404a-404b of the intraocular pseudophakic contact lens 400 have bonded to the anterior leaflet of the capsular wall in the patient's eye (such as via fibrosis).


Each pin 410 could be formed from any suitable material(s) and in any suitable manner. Note that while two pins 410 are shown here, the intraocular pseudophakic contact lens 400 could include any number of pins, including a single pin. Also note that while the pins 410 here are shown as having sharp ends, this need not be the case. For example, the pins 410 could have rounded or blunted surfaces to help the pins 410 sit on (without piercing) the anterior surface of an intraocular lens. In addition, while the pins 410 are shown here as extending through or being embedded within the extensions 406, the pins 410 could be located in any other suitable position(s). For instance, the pins 410 could be moved to the outer ends of the haptics 404a-404b, or additional pins 410 could be placed at the outer ends of the haptics 404a-404b.


As noted above, the intraocular pseudophakic contact lens 400 can be implanted during the same procedure in which an intraocular lens is being implanted or during a subsequent procedure after the intraocular lens has already been implanted in a patient's eye. The anterior leaflet of the capsular wall of the patient's eye could be used to capture and confine the haptics 404a-404b of the intraocular pseudophakic contact lens 400 under the anterior leaflet, and optionally fibrosis or re-fibrosis could occur to attach the haptics 404a-404b to the patient's eye. The pins 410 can be used to help hold the intraocular pseudophakic contact lens 400 in place.



FIGS. 6 through 8 illustrate a third example intraocular pseudophakic contact lens 600 according to this disclosure. In particular, FIG. 6 illustrates an oblique view of the intraocular pseudophakic contact lens 600, FIG. 7 illustrates a top view of the intraocular pseudophakic contact lens 600, and FIG. 8 illustrates a side view of the intraocular pseudophakic contact lens 600.


As shown in FIGS. 6 through 8, the intraocular pseudophakic contact lens 600 includes an optical lens 602, which may be the same as or similar to the optical lenses 202 and 402 described above. The intraocular pseudophakic contact lens 600 also includes multiple haptics 604a-604b and optionally multiple extensions 606. The haptics 604a-604b here are formed by loops of material, such as metal or plastic. The ends of the haptics 604a-604b are embedded within the extensions 606 in this example, although the extensions 606 could be omitted and the haptics 604a-604b could be coupled to the optical lens 602 or to a retaining ring in which the optical lens 602 is placed. Note that while the haptics 604a-604b angle downward, the haptics 604a-604b could have any other suitable arrangement. Each of the haptics 604a-604b could include a textured surface that facilitates confinement, capture, or attachment to the anterior leaflet of the capsular wall.


The intraocular pseudophakic contact lens 600 can be implanted during the same procedure in which an intraocular lens is being implanted or during a subsequent procedure after the intraocular lens has already been implanted in a patient's eye. The anterior leaflet of the capsular wall of the patient's eye could be used to capture and confine the haptics 604a-604b of the intraocular pseudophakic contact lens 600 under the anterior leaflet, and optionally fibrosis or re-fibrosis could occur to attach the haptics 604a-604b to the patient's eye.



FIGS. 9 and 10 illustrate a fourth example intraocular pseudophakic contact lens 900 according to this disclosure. In particular, FIG. 9 illustrates an oblique view of the intraocular pseudophakic contact lens 900, and FIG. 10 illustrates a side view of the intraocular pseudophakic contact lens 900.


As shown in FIGS. 9 and 10, the intraocular pseudophakic contact lens 900 has various components that are the same as or similar to those forming the intraocular pseudophakic contact lens 600. For example, the intraocular pseudophakic contact lens 900 includes an optical lens 902, multiple haptics 904a-904b, and optionally multiple extensions 906. The haptics 904a-904b form small loops that are sized and shaped so that they extend a short distance from the optical lens 902 and fit under the anterior leaflet of the capsular wall in a patient's eye after implantation. Each of the haptics 904a-904b could include a textured surface that facilitates confinement, capture, or attachment to the anterior leaflet of the capsular wall.


The intraocular pseudophakic contact lens 900 also includes one or more pins 908. Each pin 908 projects downward from an extension 906 or from the inner end of a haptic 904a-904b. The pin(s) 908 can be used to pierce the anterior surface of an intraocular lens or to rest on the anterior surface of the intraocular lens. In addition to the capture/confinement of the haptics 904a-904b by the anterior leaflet, the pins 908 can help to further hold the intraocular pseudophakic contact lens 900 in place and resist slipping of the intraocular pseudophakic contact lens 900. In some cases, the pins 908 could be used to prevent movement of the intraocular pseudophakic contact lens 900 during the period immediately after implantation and before the haptics 904a-904b of the intraocular pseudophakic contact lens 900 have bonded to the anterior leaflet of the capsular wall in the patient's eye (such as via fibrosis).


Each pin 908 could be formed from any suitable material(s) and in any suitable manner. Note that while two pins 908 are shown here, the intraocular pseudophakic contact lens 900 could include any number of pins, including a single pin. Also note that while the pins 908 here are shown as having sharp ends, this need not be the case. For example, the pins 908 could have rounded or blunted surfaces to help the pins 908 sit on (without piercing) the anterior surface of an intraocular lens. In addition, while the pins 908 are shown here as extending through or being embedded within the extensions 906, the pins 908 could be located in any other suitable position(s). For instance, the pins 908 could be moved to the outer ends of the haptics 904a-904b, or additional pins 908 could be placed at the outer ends of the haptics 904a-904b.


The intraocular pseudophakic contact lens 900 can be implanted during the same procedure in which an intraocular lens is being implanted or during a subsequent procedure after the intraocular lens has already been implanted in a patient's eye. The anterior leaflet of the capsular wall of the patient's eye could be used to capture and confine the haptics 904a-904b of the intraocular pseudophakic contact lens 900 under the anterior leaflet, and optionally fibrosis or re-fibrosis could occur to attach the haptics 904a-904b to the patient's eye. The pins 908 can be used to help hold the intraocular pseudophakic contact lens 900 in place.



FIGS. 11 and 12 illustrate a fifth example intraocular pseudophakic contact lens 1100 according to this disclosure. In particular, FIG. 11 illustrates an oblique view of the intraocular pseudophakic contact lens 1100, and FIG. 12 illustrates a side view of the intraocular pseudophakic contact lens 1100.


As shown in FIGS. 11 and 12, the intraocular pseudophakic contact lens 1100 has various components that are the same as or similar to those forming the intraocular pseudophakic contact lens 900. For example, the intraocular pseudophakic contact lens 1100 includes an optical lens 1102, multiple haptics 1104a-1104b, and optionally multiple extensions 1106. The haptics 1104a-1104b form small loops that are sized and shaped so that they extend a short distance from the optical lens 1102 and fit under the anterior leaflet of the capsular wall in a patient's eye after implantation. Each of the haptics 1104a-1104b could include a textured surface that facilitates confinement, capture, or attachment to the anterior leaflet of the capsular wall.


The intraocular pseudophakic contact lens 1100 also includes one or more pins 1108. Each pin 1108 projects downward from the outer end of a haptic 1104a-1104b. The pins 1108 are therefore positioned farther away from the optical lens 1102 compared to the pins 908. This may allow the intraocular pseudophakic contact lens 1100 to be used with larger intraocular lenses. This may also allow the pins 1108 to extend to or beyond the edges of an intraocular lens, which could help the intraocular pseudophakic contact lens 1100 to lock onto the anterior surface or sides of the intraocular lens or to reduce sliding of the intraocular pseudophakic contact lens 1100 on the intraocular lens.


The intraocular pseudophakic contact lens 1100 can be implanted during the same procedure in which an intraocular lens is being implanted or during a subsequent procedure after the intraocular lens has already been implanted in a patient's eye. The anterior leaflet of the capsular wall of the patient's eye could be used to capture and confine the haptics 1104a-1104b of the intraocular pseudophakic contact lens 1100 under the anterior leaflet, and optionally fibrosis or re-fibrosis could occur to attach the haptics 1104a-1104b to the patient's eye. The pins 1108 can be used to help hold the intraocular pseudophakic contact lens 1100 in place.



FIG. 13 illustrates a sixth example intraocular pseudophakic contact lens 1300 according to this disclosure. As shown in FIG. 13, the intraocular pseudophakic contact lens 1300 includes an optical lens 1302 and multiple haptics 1304a-1304c. The optical lens 1302 could be the same as or similar to the various optical lenses described above.


In this example, the haptics 1304a-1304c are formed by large projections that extend from the sides of the optical lens 1302, where the projections have a thickness that tapers towards the outer edges of the projections. This facilitates easier insertion of the haptics 1304a-1304c under the anterior leaflet of the capsular wall in a patient's eye. Each of the haptics 1304a-1304c could include a textured surface, such as a number of holes or other structures, that promotes confinement, capture, or attachment to the anterior leaflet of the capsular wall. While three haptics 1304a-1304c are shown here, other numbers of haptics could also be used.



FIGS. 14 and 15 illustrate a seventh example intraocular pseudophakic contact lens 1400 according to this disclosure. In particular, FIG. 14 illustrates an oblique view of the intraocular pseudophakic contact lens 1400, and FIG. 15 illustrates a cross-sectional view through the middle of the intraocular pseudophakic contact lens 1400.


As shown in FIGS. 14 and 15, the intraocular pseudophakic contact lens 1400 includes an optical lens 1402 and multiple haptics 1404a-1404b. The optical lens 1402 could be the same as or similar to the various optical lenses described above. Each of the haptics 1404a-1404b could include a textured surface, such as a number of holes or other structures, that promotes confinement, capture, or attachment to the anterior leaflet of the capsular wall.


In this example, the haptics 1404a-1404b are formed by larger projections that extend from the sides of the optical lens 1402. Each haptic 1404a-1404b includes an inner portion 1406 that is connected to the optical lens 1402 and an outer portion 1408 that is connected to the inner portion 1406, effectively forming long “wings” extending from the optical lens 1402. The outer portions 1408 have a thickness that tapers towards the outer edges of the haptics 1404a-1404b, which facilitates easier insertion of the haptics 1404a-1404b under the anterior leaflet of the capsular wall in a patient's eye. The inner portion 1406 projects outward and downward in this example, while the outer portion 1408 projects outward and slightly upward in this example (although other forms could also be used). This shape allows the haptics 1404a-1404b to be used with larger intraocular lenses while still extending under the anterior leaflet of the capsular wall.


Each of the haptics 1404a-1404b also includes a ridge 1410, and multiple ridges 1410 of multiple haptics 1404a-1404b can be used to capture one or more edges of the underlying intraocular lens. This can help to center the intraocular pseudophakic contact lens 1400 on the intraocular lens. This can also help to retain the intraocular pseudophakic contact lens 1400 in place on the intraocular lens during the healing process.



FIGS. 16 through 18 illustrate an eighth example intraocular pseudophakic contact lens 1600 according to this disclosure. In particular, FIG. 16 illustrates an oblique view of the intraocular pseudophakic contact lens 1600, FIG. 17 illustrates a top view of the intraocular pseudophakic contact lens 1600, and FIG. 18 illustrates a cross-sectional view through the middle of the intraocular pseudophakic contact lens 1600.


As shown in FIGS. 16 through 18, the intraocular pseudophakic contact lens 1600 has various components that are the same as or similar to those forming the intraocular pseudophakic contact lens 1400. For example, the intraocular pseudophakic contact lens 1600 includes an optical lens 1602 and multiple haptics 1604a-1604b. The haptics 1604a-1604b are formed by larger projections that extend from the sides of the optical lens 1602. Each haptic 1604a-1604b includes an inner portion 1606 that is connected to the optical lens 1602 (or to a retaining ring in which the optical lens 1602 is located) and an outer portion 1608 that is connected to the inner portion 1606. The outer portions 1608 have a thickness that tapers towards the outer edges of the haptics 1604a-1604b, which facilitates easier insertion of the haptics 1604a-1604b under the anterior leaflet of the capsular wall in a patient's eye. The inner portion 1606 and the outer portion 1608 both project outward and straight in this example (although other forms could also be used). This shape allows the haptics 1604a-1604b to be used with larger intraocular lenses while still extending under the anterior leaflet of the capsular wall.


Each of the haptics 1604a-1604b also includes a ridge 1610, and multiple ridges 1610 of multiple haptics 1604a-1604b can be used to capture one or more edges of the underlying intraocular lens. This can help to center the intraocular pseudophakic contact lens 1600 on the intraocular lens. This can also help to retain the intraocular pseudophakic contact lens 1600 in place on the intraocular lens during the healing process.


In addition, the intraocular pseudophakic contact lens 1600 here includes multiple segments 1612 located along the sides of the optical lens 1602. The segments 1612 denote projections from the optical lens 1602, and at least some of the segments 1612 could be coupled to the haptics 1604a-1604b (such as when ends of the haptics 1604a-1604b are embedded in the segments 1612). The segments 1612 extend downward so that the bottom surfaces of the segments 1612 are located below the optical lens 1602. As a result, when implanted into a patient's eye, the segments 1612 keep the optical lens 1602 separated from the underlying intraocular lens. Depending on the shape of the posterior surface of the optical lens 1602 and the shape of the anterior surface of the underlying intraocular lens, this could elevate the optical lens 1602 over an optical lens within the underlying intraocular lens so that the optical lenses do not contact each other.


Each of the segments 1612 could be formed from any suitable material(s) and in any suitable manner. For example, each segment 1612 could represent a portion of the material(s) forming the optical lens 1602 and therefore represent an extension of the optical lens 1602 itself. However, this need not be the case. For instance, the optical lens 1602 could be placed within a retaining ring that is integral with or attached to the segments 1612, or the segments 1612 could be secured to the optical lens 1602 itself using adhesive or other suitable connecting mechanism. Each of the segments 1612 could also have any suitable size, shape, and dimensions. For example, the segments 1612 could be smaller or larger (relative to the other structures) than what is shown in FIGS. 16 through 18. As another example, the segments 1612 could denote curved structures that leave small open areas between the segments 1612 and the optical lens 1602, or the segments 1612 could be solid structures that leave no open areas between the segments 1612 and the optical lens 1602.


The ability to space the optical lens 1602 away from the underlying intraocular lens could provide various benefits. For example, elevating the optical lens 1602 over the underlying intraocular lens may allow for an increase in aqueous flow between the anterior surface of the intraocular lens and the posterior surface of the optical lens 1602. An increased flow of aqueous between the lenses could help to reduce lens deposits on either or both of the lenses. Also, the presence of aqueous between the lenses can help to improve the optic or image quality of the combined lens system. In addition, by providing more space between the lenses, the intraocular pseudophakic contact lens 1600 could be used with a wider range of intraocular lenses that have varying anterior curvature surfaces, allowing the intraocular pseudophakic contact lens 1600 to be used with a wider range of intraocular lens models and powers.



FIGS. 19 through 21 illustrate a ninth example intraocular pseudophakic contact lens 1900 according to this disclosure. In particular, FIG. 19 illustrates an oblique view of the intraocular pseudophakic contact lens 1900, FIG. 20 illustrates a top view of the intraocular pseudophakic contact lens 1900, and FIG. 21 illustrates a cross-sectional view through the middle of the intraocular pseudophakic contact lens 1900.


As shown in FIGS. 19 through 21, the intraocular pseudophakic contact lens 1900 has various components that are the same as or similar to those forming the intraocular pseudophakic contact lens 1600. For example, the intraocular pseudophakic contact lens 1900 includes an optical lens 1902 and multiple haptics 1904a-1904b. The haptics 1904a-1904b are formed by larger projections that extend from the sides of the optical lens 1902. Each haptic 1904a-1904b includes an inner portion 1906 that is connected to the optical lens 1902 (or to a retaining ring in which the optical lens 1902 is located) and an outer portion 1908 that is connected to the inner portion 1906. Each of the haptics 1904a-1904b also includes a ridge 1910, and multiple ridges 1910 of multiple haptics 1904a-1904b can be used to capture one or more edges of the underlying intraocular lens. In addition, the intraocular pseudophakic contact lens 1900 includes multiple segments 1912 along the sides of the optical lens 1902. The segments 1912 extend downward so that the bottom surfaces of the segments 1912 are located below the optical lens 1902.


The haptics 1904a-1904b in this example include thicker outer portions 1908 with larger ridges 1910 compared to the corresponding components of the intraocular pseudophakic contact lens 1600. This allows the haptics 1904a-1904b to be used with even larger intraocular lenses. Moreover, each of the ridges 1910 includes a lip 1911 that can facilitate the capture of the underlying intraocular lens. Each of the lips 1911 denotes any suitable inward projection from the corresponding ridge 1910.


Again, when implanted into a patient's eye, the segments 1912 help to keep the optical lens 1902 separated from the underlying intraocular lens. Depending on the shape of the posterior surface of the optical lens 1902 and the shape of the anterior surface of the underlying intraocular lens, this could elevate the optical lens 1902 over an optical lens within the underlying intraocular lens so that the optical lenses do not contact each other. The ability to space the optical lens 1902 away from the underlying intraocular lens could provide various benefits, such as those described above with respect to the intraocular pseudophakic contact lens 1600.



FIGS. 22 through 24 illustrate a tenth example intraocular pseudophakic contact lens 2200 according to this disclosure. In particular, FIG. 22 illustrates an oblique view of the intraocular pseudophakic contact lens 2200, FIG. 23 illustrates a top view of the intraocular pseudophakic contact lens 2200, and FIG. 24 illustrates a side view of the intraocular pseudophakic contact lens 2200.


As shown in FIGS. 22 through 24, the intraocular pseudophakic contact lens 2200 has various components that are the same as or similar to those forming the intraocular pseudophakic contact lens 1400. For example, the intraocular pseudophakic contact lens 2200 includes an optical lens 2202 and multiple haptics 2204a-2204c. The haptics 2204a-2204c are formed by projections that extend from the sides of the optical lens 2202. Each haptic 2204a-2204c includes an inner portion 2206 that is connected to the optical lens 2202 (or to a retaining ring in which the optical lens 2202 is located) and an outer portion 2208 that is connected to the inner portion 2206. Each of the haptics 2204a-2204c also includes a ridge 2210, and multiple ridges 2210 of multiple haptics 2204a-2204c can be used to capture one or more edges of the underlying intraocular lens. While not shown here, at least one of the ridges 2210 may include a lip, which can be the same as or similar to the lip 1911 and which can facilitate the capture and retention of the underlying intraocular lens.


In this example, the haptics 2204a-2204c are formed by large projections that extend from the sides of the optical lens 2202, where the projections have a thickness that tapers towards the outer edges of the projections. This facilitates easier insertion of the haptics 2204a-2204c under the anterior leaflet of the capsular wall in a patient's eye. Each of the haptics 2204a-2204c could include a textured surface, such as a number of holes or other structures, that promotes confinement, capture, or attachment to the anterior leaflet of the capsular wall. While three haptics 2204a-2204c are shown here, other numbers of haptics could also be used. In some embodiments, the haptics 2204a-2204c can be positioned at an even spacing of 120°.


Also in this example, an alignment marking 2212 is provided on one of the haptics 2204b. In this particular example, the alignment marking 2212 represents the letter “R,” although any other suitable marking(s) may be used here in any suitable location(s). The alignment marking 2212 can be used to identify the proper orientation of the intraocular pseudophakic contact lens 2200, such as by identifying the haptic 2204b that is to be positioned on the right side of the intraocular pseudophakic contact lens 2200 (from the perspective of the surgeon or other medical personnel) after implantation.



FIGS. 25 through 27 illustrate an eleventh example intraocular pseudophakic contact lens according to this disclosure. In particular, FIG. 25 illustrates an oblique view of the intraocular pseudophakic contact lens 2500, FIG. 26 illustrates a top view of the intraocular pseudophakic contact lens 2500, and FIG. 27 illustrates a side view of the intraocular pseudophakic contact lens 2500.


As shown in FIGS. 25 through 27, the intraocular pseudophakic contact lens 2500 has various components that are the same as or similar to those forming the intraocular pseudophakic contact lens 2200. For example, the intraocular pseudophakic contact lens 2500 includes an optical lens 2502 and multiple haptics 2504a-2504d. The haptics 2504a-2504d are formed by projections that extend from the sides of the optical lens 2502. Each haptic 2504a-2504d includes an inner portion 2506 that is connected to the optical lens 2502 (or to a retaining ring in which the optical lens 2502 is located) and an outer portion 2508 that is connected to the inner portion 2506. Each of the haptics 2504a-2504d also includes a ridge 2510, and multiple ridges 2510 of multiple haptics 2504a-2504d can be used to capture one or more edges of the underlying intraocular lens. While not shown here, at least one of the ridges 2510 may include a lip, which can be the same as or similar to the lip 1911 and which can facilitate the capture and retention of the underlying intraocular lens.


In this example, the haptics 2504a-2504d are formed by large projections that extend from the sides of the optical lens 2502, where the projections have a thickness that tapers towards the outer edges of the projections. This facilitates easier insertion of the haptics 2504a-2504d under the anterior leaflet of the capsular wall in a patient's eye. Each of the haptics 2504a-2504d could include a textured surface, such as a number of holes or other structures, that promotes confinement, capture, or attachment to the anterior leaflet of the capsular wall. While four haptics 2504a-2504d are shown here in two groups on opposite sides of the optical lens 2502, other numbers and arrangements of haptics could also be used.


While various prior approaches have secured an “add-on” lens to an intraocular lens, these prior approaches require a specific add-on lens to be designed for use with a specific intraocular lens and the specific intraocular lens to be designed for use with the specific add-on lens. That is, the add-on lens can only be used with a specific type of intraocular lens, where that intraocular lens is designed specifically for use with that add-on lens. As particular examples, an add-on lens may include haptics or other structures that are designed to mate with corresponding structures of specific intraocular lenses, or an intraocular lens may have a recess designed to receive a specific type of add-on lens. This can be problematic for a number of reasons. For instance, many patients already have existing intraocular lenses, and it may be impractical or even dangerous to try to remove those existing intraocular lenses in order to implant new intraocular lenses that are designed for use with add-on lenses.


The embodiments of the intraocular pseudophakic contact lenses shown in FIGS. 1 through 27 can help to alleviate these problems since the intraocular pseudophakic contact lenses can be secured over intraocular lenses by capturing and confining the haptics of the intraocular pseudophakic contact lenses using the anterior leaflets of capsular walls. In some cases, this could also involve physical bonding of the haptics to the anterior leaflets of capsular walls, such as via a fibrosis or re-fibrosis mechanism. In other words, the intraocular pseudophakic contact lenses do not need to be designed to work specifically with particular structures of any specific intraocular lens. The intraocular lens being used with an intraocular pseudophakic contact lens need not have any predefined structures that are provided for coupling to an intraocular pseudophakic contact lens. Rather, the intraocular pseudophakic contact lenses of FIGS. 1 through 27 can simply be sized so that, when the intraocular pseudophakic contact lens is placed on an intraocular lens, it can be secured in place through capture and confinement by (and possibly bonding with) the anterior leaflet of the capsular wall. This allows the intraocular pseudophakic contact lenses of FIGS. 1 through 27 to be used with a wide variety of intraocular lenses, including different types of intraocular lenses and including existing intraocular lenses already implanted into patients. There is no need to remove an existing intraocular lens from a patient in order to install a new intraocular lens and an intraocular pseudophakic contact lens.


Moreover, the intraocular pseudophakic contact lenses of FIGS. 1 through 27 could be easily removed from patients' eyes, such as any suitable time after implantation or prior to bonding of the haptics to the capsular walls (assuming fibrosis or re-fibrosis holds the intraocular pseudophakic contact lenses in place). Among other things, this allows one intraocular pseudophakic contact lens to be removed and replaced with a different intraocular pseudophakic contact lens if a different refractive correction is needed or desired.


The various intraocular pseudophakic contact lenses described above could have any suitable size, shape, and dimensions. For example, the intraocular pseudophakic contact lenses could be made available in a range of diameters from about 4 mm to about 6 mm. Also, the intraocular pseudophakic contact lenses could be made available with varying base curvatures for their optical lenses. Of course, an intraocular pseudophakic contact lens could also be custom designed for a particular patient's eye, such as when one or more specific curvatures are needed to correct for residual refractive error in the particular patient's eye.


The intraocular pseudophakic contact lenses disclosed here can be implanted non-invasively in patients' eyes and easily positioned on intraocular lenses. The implantation is non-invasive because an intraocular pseudophakic contact lens is being installed on the anterior surface of an intraocular lens, which is typically easily accessible by a surgeon or other personnel during an implantation procedure. The implantation is also non-invasive because the intraocular pseudophakic contact lenses can be attached to intraocular lenses without requiring attachment of the intraocular pseudophakic contact lenses to anatomical structures within the patients' eyes, such as to the suculus of a patient's eye.


The non-invasive implantation and easy positioning of an intraocular pseudophakic contact lens provide a safe and effective refractive surgical procedure to correct unwanted residual refractive error, such as after a lensectomy procedure. As a refractive modality, the intraocular pseudophakic contact lenses contribute to a surgeon's ability to alter the current refractive error of a pseudophakic patient in an effort to adjust the patient's vision to achieve a finely-tuned desired refraction. Specific examples of this functionality include allowing adjustments to a patient's eye in order to achieve unilateral or bilateral emmetropia, to induce unilateral myopia to allow for intermediate and near visual function, to introduce multi-focality, and to treat unwanted residual astigmatism.


If the haptics of an intraocular pseudophakic contact lens include ridges along their bottom surfaces, the ridges can be used to center the intraocular pseudophakic contact lens on an underlying intraocular lens as described above. If the intraocular pseudophakic contact lens includes three haptics with associated ridges, the ridges could help to perfectly center the intraocular pseudophakic contact lens on the underlying intraocular lens. Such an approach allows the ridges of the intraocular pseudophakic contact lens' haptics to capture the underlying intraocular lens at the edge and perfectly line up the optical center of the intraocular pseudophakic contact lens' optic with the optical center of the intraocular lens. This alignment helps to reduce or avoid induced optical aberrations or induced prisms caused by optical center misalignment. This provides a strong contributing benefit over conventional refractive fine-tuning modalities.


Note that in any of the above examples, the intraocular pseudophakic contact lens could possibly be designed so that only the haptics of the intraocular pseudophakic contact lens extend under the anterior leaflet of the capsular wall in a patient's eye. This allows the haptics to be captured and confined by the anterior leaflet while leaving the optical lens of the intraocular pseudophakic contact lens free and generally unobscured by the surrounding tissue in the patient's eye.


Also note that, in some embodiments, the surgical tool disclosed in U.S. patent application Ser. No. 16/280,235 (which is hereby incorporated by reference in its entirety) may be used to help implant an intraocular pseudophakic contact lens. For example, this tool may be used to separate at least part of the anterior leaflet of a patient's eye from an implanted intraocular lens, allowing haptics of the intraocular pseudophakic contact lens to be inserted between the anterior leaflet and the intraocular lens. As another example, this tool may be used to separate the anterior leaflet of a patient's eye from an implanted intraocular pseudophakic contact lens, allowing the intraocular pseudophakic contact lens to be removed (and possibly replaced).


Although FIGS. 1 through 27 illustrate examples of intraocular pseudophakic contact lens, various changes may be made to FIGS. 1 through 27. For example, any suitable combination of features shown in FIGS. 1 through 27 could be used together in a single intraocular pseudophakic contact lens, whether or not that specific combination of features is shown in the figures or described above. As a particular example, any of the intraocular pseudophakic contact lenses shown in FIGS. 1 through 27 could include one or more pins at one or more desired locations, one or more ridges along the bottom surface(s) of its haptic(s) to aid in the capture of an intraocular lens and centration on the intraocular lens, and/or one or more lips to help capture the intraocular lens. Also, each intraocular pseudophakic contact lens could include any suitable number of each component shown in any of the figures. While the figures have shown the intraocular pseudophakic contact lenses as having two, three, or four haptics (some at an even spacing of 120° or 180°), any number of haptics (with or without associated pins, ridges, lips, or other structures) could be used. Further, the forms of the haptics shown here are examples only, and any other suitable structures could be used to capture, confine, or attach to the anterior leaflet of a capsular wall in a patient's eye. In addition, a number of other features could be used at one or more locations of the intraocular pseudophakic contact lenses. For instance, one or more alignment markings could be provided to identify proper alignment of the intraocular pseudophakic contact lens with the intraocular lens, or one or more drug-eluting materials could be placed on top, side, or bottom surfaces of the optical lenses in the intraocular pseudophakic contact lenses.



FIG. 28 illustrates an example intraocular lens and an example intraocular pseudophakic contact lens in a patient's eye 2800 according to this disclosure. As shown in FIG. 28, the eye 2800 includes a cornea 2802, a sclera 2804, and an iris 2806. The cornea 2802 represents the clear front portion of the eye 2800 through which light passes to enter into the eye 2800. The sclera 2804 is the tough outer white portion of the eye. The iris 2806 controls the size of the eye's pupil to thereby control the amount of light from the cornea 2802 that enters into the interior of the eye 2800.


The eye 2800 also includes a capsular bag 2808, which typically holds the natural crystalline lens of the eye 2800. However, in this example, the natural crystalline lens has been removed and replaced with an intraocular lens 2810 having an optical lens 2812 and one or more haptics 2814. The optical lens 2812 of the intraocular lens 2810 receives light entering the eye and focuses the light onto the retina of the eye 2800. The haptics 2814 of the intraocular lens 2810 help to hold the intraocular lens 2810 within the capsular bag 2808 so that the optical lens 2812 of the intraocular lens 2810 is in a desired position within the eye.


An intraocular pseudophakic contact lens 2816 has also been placed on the intraocular lens 2810 within the capsular bag 2808. The intraocular pseudophakic contact lens 2816 can represent any of the intraocular pseudophakic contact lenses described above or any other suitable intraocular pseudophakic contact lens. The intraocular pseudophakic contact lens 2816 is placed on the anterior surface of the intraocular lens 2810, meaning the front surface of the intraocular lens 2810 with respect to the eye 2800. Light enters through the cornea 2802 and passes through the pupil before entering the intraocular pseudophakic contact lens 2816, which modifies the light. The modified light then passes through the optical lens 2812 of the intraocular lens 2810 and is again modified. The twice-modified light then travels through the remainder of the eye 2800 to reach the retina at the back of the eye 2800.


As described above, the intraocular pseudophakic contact lens 2816 includes one or more haptics that extend a short distance and fit under an anterior leaflet 2818 of the capsular bag 2808. This allows the haptics to be captured and confined by the anterior leaflet 2818 (and possibly attach to the anterior leaflet 2818 via fibrosis or re-fibrosis). The anterior leaflet 2818 represents the outer portion of the front side of the capsular bag 2808 that remains after a capsulorhexis is formed in the capsular bag 2808. The insertion of the haptics of the intraocular pseudophakic contact lens 2816 under the anterior leaflet 2818 helps to secure the intraocular pseudophakic contact lens 2816 in place. In some cases, the healing process in the eye 2800 can cause fibrosis to occur, which could also attach the anterior leaflet 2818 to the haptics of the intraocular pseudophakic contact lens 2816.


Note that the haptics of the intraocular pseudophakic contact lens 2816 are shorter or smaller than the haptics 2814 of the intraocular lens 2810. This is because the haptics 2814 of the intraocular lens 2810 extend generally to the top and bottom of the capsular bag 2808 and help to hold the intraocular lens 2810 in the proper position within the capsular bag 2808. The haptics of the intraocular pseudophakic contact lens 2816 need not extend to the top and bottom of the capsular bag 2808 and instead may only extend a short distance under the anterior leaflet 2818.


By properly selecting the optical lens of the intraocular pseudophakic contact lens 2816, the intraocular pseudophakic contact lens 2816 can ideally correct any residual refractive error that remains after implantation of the intraocular lens 2810. If necessary, the intraocular pseudophakic contact lens 2816 can also be removed and replaced with a different intraocular pseudophakic contact lens. This may be needed or desired if the intraocular pseudophakic contact lens 2816 does not properly correct the residual refractive error or if the intraocular pseudophakic contact lens 2816 actually causes additional refractive errors.


Although FIG. 28 illustrates one example of an intraocular lens and one example of an intraocular pseudophakic contact lens in a patient's eye, various changes may be made to FIG. 28. For example, the intraocular lens 2810 could be attached to any other intraocular pseudophakic contact lens. Also, there are a number of intraocular lenses available, and an intraocular pseudophakic contact lens could be coupled to any other suitable intraocular lens in the eye 2800.



FIG. 29 illustrates an example method 2900 for using an intraocular pseudophakic contact lens with an intraocular lens according to this disclosure. As shown in FIG. 29, residual refractive error in a patient's eye having an intraocular lens is identified at step 2902. This could include, for example, personnel testing the patient's vision and identifying any refractive error that remains after implantation of the intraocular lens 2810. The testing could be done in any suitable manner, such as by using intraoperative wavefront aberrometry. One goal of the testing can be to identify what refractive errors exist in the patient's eye after implantation of the intraocular lens in the patient's eye. This testing could be performed at any suitable time, such as after a lensectomy procedure.


An intraocular pseudophakic contact lens (IOPCL) is selected to (ideally) correct the identified residual refractive error at step 2904. This could include, for example, personnel selecting an intraocular pseudophakic contact lens from a kit, where the selected intraocular pseudophakic contact lens has an optical lens that substantially neutralizes the identified residual refractive error. This could also include the personnel selecting an optical lens from a kit and inserting the optical lens into an intraocular pseudophakic contact lens, where the selected optical lens substantially cancels the identified residual refractive error. This could further include the personnel obtaining an intraocular pseudophakic contact lens having a custom-designed optical lens or obtaining a custom-designed optical lens for insertion into an intraocular pseudophakic contact lens, where the custom-designed optical lens substantially cancels the identified residual refractive error. In general, any mechanism can be used to obtain a suitable intraocular pseudophakic contact lens.


The selected intraocular pseudophakic contact lens is inserted into the patient's eye at step 2906. This could include, for example, a surgeon or other personnel forming a small incision in the patient's eye and inserting the intraocular pseudophakic contact lens into the eye through the incision. The intraocular pseudophakic contact lens can be rolled, folded, or otherwise reduced in cross-sectional size in order to insert the intraocular pseudophakic contact lens through a smaller incision.


One or more haptics of the intraocular pseudophakic contact lens are inserted under the anterior leaflet of the capsular wall in the patient's eye at step 2908. This could include, for example, the surgeon or other personnel placing the intraocular pseudophakic contact lens 2816 at a desired position (and possibly in a desired orientation) on the intraocular lens 2810. This could also include the surgeon or other personnel moving the intraocular pseudophakic contact lens 2816 so that its haptics (in whatever form) slide under the anterior leaflet 2818 of the capsular bag 2808.


A vision test for the patient occurs at step 2910. The vision test could be done in any suitable manner, such as by using intraoperative wavefront aberrometry. This vision test could also be performed at any suitable time, such as during the surgical procedure in which the intraocular pseudophakic contact lens is being implanted or after the surgical procedure has been completed. A determination is made whether the tested vision is satisfactory at step 2912. This could include, for example, personnel determining whether the patient's eye is still experiencing any residual refractive error and, if so, to what extent.


A determination is made whether to change the intraocular pseudophakic contact lens at step 2914. This could include, for example, the personnel and the patient determining whether the remaining residual refractive error (if any) is inconvenient or otherwise problematic for the patient. If so, different steps could be taken to try and fix the problem. For instance, the currently-implanted intraocular pseudophakic contact lens could be repositioned to adjust for cylinder axis correction. If that fails, another intraocular pseudophakic contact lens is selected at step 2916. This could include, for example, personnel selecting another intraocular pseudophakic contact lens that (ideally) provides a better refractive correction for the patient's eye compared to the currently-inserted intraocular pseudophakic contact lens. The currently-inserted intraocular pseudophakic contact lens is removed from the patient's eye at step 2918. This could include, for example, the surgeon or other personnel sliding the haptics of the currently-inserted intraocular pseudophakic contact lens 2816 from under the anterior leaflet 2818 and removing the currently-inserted intraocular pseudophakic contact lens 2816 from the patient's eye. The process then returns to step 2906, where the newly-selected intraocular pseudophakic contact lens can be inserted into the patient's eye and the vision test can be repeated.


After the process shown in FIG. 29 is over, the haptics of the implanted intraocular pseudophakic contact lens 2816 can be captured/confined by the anterior leaflet 2818 of the capsular bag 2808 in the patient's eye. This helps to hold the intraocular pseudophakic contact lens 2816 in place. Moreover, the healing process in the patient's eye can optionally cause fibrosis or re-fibrosis to occur, which could physically attach the haptics of the implanted intraocular pseudophakic contact lens 2816 to the anterior leaflet 2818 of the capsular bag 2808.


Although FIG. 29 illustrates one example of a method 2900 for using an intraocular pseudophakic contact lens with an intraocular lens, various changes may be made to FIG. 29. For example, while shown as a series of steps, various steps in FIG. 29 could overlap, occur in parallel, occur in a different order, or occur any number of times.


It may be advantageous to set forth definitions of certain words and phrases used throughout this patent document. The terms “include” and “comprise,” as well as derivatives thereof, mean inclusion without limitation. The term “or” is inclusive, meaning and/or. The phrase “associated with,” as well as derivatives thereof, may mean to include, be included within, interconnect with, contain, be contained within, connect to or with, couple to or with, be communicable with, cooperate with, interleave, juxtapose, be proximate to, be bound to or with, have, have a property of, have a relationship to or with, or the like. The phrase “at least one of,” when used with a list of items, means that different combinations of one or more of the listed items may be used, and only one item in the list may be needed. For example, “at least one of: A, B, and C” includes any of the following combinations: A, B, C, A and B, A and C, B and C, and A and B and C.


The description in this patent document should not be read as implying that any particular element, step, or function is an essential or critical element that must be included in the claim scope. Also, none of the claims is intended to invoke 35 U.S.C. § 112(f) with respect to any of the appended claims or claim elements unless the exact words “means for” or “step for” are explicitly used in the particular claim, followed by a participle phrase identifying a function. Use of terms such as (but not limited to) “mechanism,” “module,” “device,” “unit,” “component,” “element,” “member,” “apparatus,” “machine,” “system,” “processor,” “processing device,” or “controller” within a claim is understood and intended to refer to structures known to those skilled in the relevant art, as further modified or enhanced by the features of the claims themselves, and is not intended to invoke 35 U.S.C. § 112(f).


While this disclosure has described certain embodiments and generally associated methods, alterations and permutations of these embodiments and methods will be apparent to those skilled in the art. Accordingly, the above description of example embodiments does not define or constrain this disclosure. Other changes, substitutions, and alterations are also possible without departing from the spirit and scope of this disclosure, as defined by the following claims.

Claims
  • 1. An apparatus comprising: an intraocular pseudophakic contact lens comprising: an optical lens configured to at least partially correct a residual refractive error in an eye, the residual refractive error comprising a refractive error that exists in the eye after implantation of an artificial intraocular lens in the eye; andhaptics extending radially from the optical lens and configured to be inserted under an anterior leaflet of a capsular wall in the eye in order to capture and confine the haptics under the anterior leaflet and secure the intraocular pseudophakic contact lens against the artificial intraocular lens;wherein anterior surfaces of the haptics comprise textured capsular wall-engaging surfaces configured to contact an inner capsular wall surface of the anterior leaflet, the textured capsular wall-engaging surfaces configured to promote confinement, capture, or attachment of the haptics; andwherein posterior surfaces of the haptics comprise ridges configured to capture at least one edge of the artificial intraocular lens in order to secure the intraocular pseudophakic contact lens to the artificial intraocular lens.
  • 2. The apparatus of claim 1, wherein the optical lens is positioned above the anterior and posterior surfaces of the haptics such that the anterior and posterior surfaces of the haptics are positioned below at least part of a posterior surface of the optical lens.
  • 3. The apparatus of claim 1, wherein: each of the haptics comprises an inner portion and an outer portion;the inner portion of each haptic couples the optical lens and the outer portion of the haptic; andthe outer portion of each haptic has a thickness that tapers from a larger thickness adjacent the inner portion of the haptic to a smaller thickness adjacent an outer edge of the haptic.
  • 4. The apparatus of claim 3, wherein the inner portion of each haptic projects outward and downward from the optical lens.
  • 5. The apparatus of claim 4, wherein the outer portion of each haptic projects outward and upward from the inner portion of the haptic.
  • 6. The apparatus of claim 3, wherein the inner portion of each haptic tapers from a larger thickness adjacent the optical lens to a smaller thickness adjacent the outer portion of the haptic.
  • 7. The apparatus of claim 1, wherein: an anterior surface of the optical lens is convex; anda posterior surface of the optical lens is concave.
  • 8. The apparatus of claim 1, wherein an anterior surface of the optical lens and portions of the anterior surfaces of the haptics collectively form a convex surface.
  • 9. The apparatus of claim 1, wherein the intraocular pseudophakic contact lens comprises at least three haptics.
  • 10. The apparatus of claim 1, wherein the textured capsular wall-engaging surfaces are configured to bond to the inner capsular wall surface of the anterior leaflet through fibrosis.
  • 11. An apparatus comprising: an intraocular pseudophakic contact lens comprising: an optical lens configured to at least partially correct a residual refractive error in an eye, the residual refractive error comprising a refractive error that exists in the eye after implantation of an artificial intraocular lens in the eye; andhaptics extending radially from the optical lens and configured to be inserted under an anterior leaflet of a capsular wall in the eye in order to capture and confine the haptics under the anterior leaflet and secure the intraocular pseudophakic contact lens against the artificial intraocular lens;wherein anterior surfaces of the haptics are configured to contact an inner capsular wall surface of the anterior leaflet;wherein posterior surfaces of the haptics comprise ridges configured to capture at least one edge of the artificial intraocular lens in order to secure the intraocular pseudophakic contact lens to the artificial intraocular lens;wherein each of the haptics comprises an inner portion and an outer portion, the inner portion of each haptic coupling the optical lens and the outer portion of the haptic, the outer portion of each haptic having a thickness that tapers from a larger thickness adjacent the inner portion of the haptic to a smaller thickness adjacent an outer edge of the haptic, the inner portion of each haptic projecting outward and downward from the optical lens; andwherein, for each haptic, the ridge is defined where the larger thickness of the outer portion of the haptic meets a smaller thickness of the inner portion of the haptic.
  • 12. A system comprising: an artificial intraocular lens comprising a first optical lens and first haptics configured to be implanted within a capsular bag in an eye; andan intraocular pseudophakic contact lens comprising: a second optical lens configured to at least partially correct a residual refractive error in the eye, the residual refractive error comprising a refractive error that exists in the eye after implantation of the artificial intraocular lens in the eye; andsecond haptics extending radially from the second optical lens and configured to be inserted under an anterior leaflet of a capsular wall in the eye in order to capture and confine the second haptics under the anterior leaflet and secure the intraocular pseudophakic contact lens against the artificial intraocular lens;wherein anterior surfaces of the second haptics are configured to contact an inner capsular wall surface of the anterior leaflet; andwherein posterior surfaces of the second haptics comprise ridges configured to capture at least one edge of the artificial intraocular lens in order to secure the intraocular pseudophakic contact lens to the artificial intraocular lens.
  • 13. The system of claim 12, wherein the second optical lens is positioned above the anterior and posterior surfaces of the second haptics such that the anterior and posterior surfaces of the second haptics are positioned below at least part of a posterior surface of the second optical lens.
  • 14. The system of claim 12, wherein: each of the second haptics comprises an inner portion and an outer portion;the inner portion of each second haptic couples the second optical lens and the outer portion of the second haptic; andthe outer portion of each second haptic has a thickness that tapers from a larger thickness adjacent the inner portion of the second haptic to a smaller thickness adjacent an outer edge of the second haptic.
  • 15. The system of claim 14, wherein the inner portion of each second haptic projects outward and downward from the second optical lens.
  • 16. The system of claim 15, wherein the outer portion of each second haptic projects outward and upward from the inner portion of the second haptic.
  • 17. The system of claim 15, wherein, for each second haptic, the ridge is defined where the larger thickness of the outer portion of the second haptic meets a smaller thickness of the inner portion of the second haptic.
  • 18. The system of claim 14, wherein the inner portion of each second haptic tapers from a larger thickness adjacent the second optical lens to a smaller thickness adjacent the outer portion of the second haptic.
  • 19. The system of claim 12, wherein: an anterior surface of the second optical lens is convex; anda posterior surface of the second optical lens is concave.
  • 20. The system of claim 12, wherein an anterior surface of the second optical lens and portions of the anterior surfaces of the second haptics collectively form a convex surface.
  • 21. An apparatus comprising: an intraocular pseudophakic contact lens comprising: an optical lens configured to at least partially correct a residual refractive error in an eye, the residual refractive error comprising a refractive error that exists in the eye after implantation of an artificial intraocular lens in the eye; andhaptics extending radially from the optical lens and configured to be inserted under an anterior leaflet of a capsular wall in the eye in order to capture and confine the haptics under the anterior leaflet and secure the intraocular pseudophakic contact lens against the artificial intraocular lens;wherein anterior surfaces of the haptics are configured to contact an inner capsular wall surface of the anterior leaflet;wherein posterior surfaces of the haptics comprise ridges configured to capture at least one edge of the artificial intraocular lens in order to secure the intraocular pseudophakic contact lens to the artificial intraocular lens;wherein each of the haptics comprises an inner portion and an outer portion;wherein the inner portion of each haptic couples the optical lens and the outer portion of the haptic;wherein the outer portion of each haptic has a thickness that tapers from a larger thickness adjacent the inner portion of the haptic to a smaller thickness adjacent an outer edge of the haptic;wherein the inner portion of each haptic projects outward and downward from the optical lens; andwherein the outer portion of each haptic projects outward and upward from the inner portion of the haptic.
CROSS-REFERENCE TO RELATED APPLICATIONS AND PRIORITY CLAIM

This application is a continuation-in-part of U.S. patent application Ser. No. 15/646,254 filed on Jul. 11, 2017, which is a continuation-in-part of U.S. patent application Ser. No. 14/860,629 filed on Sep. 21, 2015 (now U.S. Pat. No. 10,159,562), which claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application No. 62/053,771 filed on Sep. 22, 2014. All of these applications are hereby incorporated by reference in their entirety.

US Referenced Citations (243)
Number Name Date Kind
4124905 Clark Nov 1978 A
5071432 Baikoff Dec 1991 A
5078742 Dahan Jan 1992 A
5098444 Feaster Mar 1992 A
5133747 Feaster Jul 1992 A
5201762 Hauber Apr 1993 A
5217491 Vanderbilt Jun 1993 A
5266241 Parekh Nov 1993 A
5275623 Sarfarazi Jan 1994 A
5354334 Fedorov et al. Oct 1994 A
5358520 Patel Oct 1994 A
5443506 Garabet Aug 1995 A
5443507 Jacobi Aug 1995 A
5522891 Klaas Jun 1996 A
5539016 Kunzier et al. Jul 1996 A
5684560 Roffman et al. Nov 1997 A
5693095 Freeman et al. Dec 1997 A
5699142 Lee et al. Dec 1997 A
5728156 Gupta Mar 1998 A
5755786 Woffinden et al. May 1998 A
5769890 McDonald Jun 1998 A
5782911 Herrick Jul 1998 A
5824074 Koch Oct 1998 A
6027531 Tassignon Feb 2000 A
6030416 Huo et al. Feb 2000 A
6045577 Woffinden et al. Apr 2000 A
6113633 Portney Sep 2000 A
6142625 Sawano et al. Nov 2000 A
6169127 Lohmann et al. Jan 2001 B1
6197057 Peyman et al. Mar 2001 B1
6200342 Tassignon Mar 2001 B1
6217171 Auten et al. Apr 2001 B1
6217612 Woods Apr 2001 B1
6197058 Portney Jun 2001 B1
6277146 Peyman et al. Aug 2001 B1
6419697 Kelman Jul 2002 B1
6454801 Portney Sep 2002 B1
6464725 Skotton Oct 2002 B2
6488708 Sarfarazi Dec 2002 B2
6554859 Lang et al. Apr 2003 B1
6554860 Hoffmann et al. Apr 2003 B2
6558420 Green May 2003 B2
6582076 Roffman et al. Jun 2003 B1
6616691 Tran Sep 2003 B1
6616692 Glick et al. Sep 2003 B1
6645246 Weinschenk, III et al. Nov 2003 B1
6705729 Piers et al. Mar 2004 B2
6749634 Hanna Jun 2004 B2
6767363 Bandhauer et al. Jul 2004 B1
6797004 Brady et al. Sep 2004 B1
6818017 Shu Nov 2004 B1
6827738 Willis et al. Dec 2004 B2
6851803 Wooley et al. Feb 2005 B2
6860601 Shadduck Mar 2005 B2
6880558 Perez Apr 2005 B2
6926736 Peng et al. Aug 2005 B2
6952313 Schrader Oct 2005 B2
6960230 Haefliger Nov 2005 B2
6960231 Tran Nov 2005 B2
6991651 Portney Jan 2006 B2
7008448 Lipshitz et al. Mar 2006 B2
7029497 Zhang et al. Apr 2006 B2
7036931 Lindacher et al. May 2006 B2
7081134 Cukrowski Jul 2006 B2
7101397 Aharoni Sep 2006 B2
7111938 Andino et al. Sep 2006 B2
7118597 Miller et al. Oct 2006 B2
7150760 Zhang Dec 2006 B2
7186266 Peyman Mar 2007 B2
7220278 Peyman May 2007 B2
7223288 Zhang et al. May 2007 B2
7238201 Portney et al. Jun 2007 B2
7279006 Vincent Oct 2007 B2
7311194 Jin et al. Dec 2007 B2
7316713 Zhang Jan 2008 B2
7338161 Chauveau et al. Mar 2008 B2
7452378 Zadno-Azizi et al. Nov 2008 B2
7453646 Lo Nov 2008 B2
7462193 Nagamoto Dec 2008 B2
7572007 Simpson Aug 2009 B2
7591849 Richardson Sep 2009 B2
7604349 Blum et al. Oct 2009 B2
7744647 Barrett Jun 2010 B2
7794498 Pinchuk Sep 2010 B2
7806929 Brown Oct 2010 B2
7842087 Ben Nun Nov 2010 B2
7871162 Weeber Jan 2011 B2
7871437 Hermans et al. Jan 2011 B2
7875661 Salamone Jan 2011 B2
7892264 Sanders et al. Feb 2011 B2
7905917 Altmann Mar 2011 B2
7918886 Aharoni et al. Apr 2011 B2
7942929 Linhardt et al. May 2011 B2
7955704 Lowery et al. Jun 2011 B2
8012204 Weinschenk, III et al. Sep 2011 B2
8034107 Stenger Oct 2011 B2
8109999 Hampp Feb 2012 B2
8133274 Zhou et al. Mar 2012 B2
8197541 Schedler Jun 2012 B2
8222360 Liao Jul 2012 B2
8231219 Weeber Jul 2012 B2
8273123 Ben Nun Sep 2012 B2
8324256 Domschke et al. Dec 2012 B2
8337552 Kobayashi et al. Dec 2012 B2
8377124 Hong et al. Feb 2013 B2
8419791 Toop Apr 2013 B2
8430928 Liao Apr 2013 B2
8491651 Tsai et al. Jul 2013 B2
8523942 Cumming Sep 2013 B2
8530590 Hu et al. Sep 2013 B2
8579972 Rombach Nov 2013 B2
8603167 Rombach Dec 2013 B2
8608799 Blake Dec 2013 B2
8636358 Binder Jan 2014 B2
8680172 Liao Mar 2014 B2
8696746 Wanders et al. Apr 2014 B2
8834566 Jones Sep 2014 B1
8852274 Doraiswamy et al. Oct 2014 B2
8858626 Noy Oct 2014 B2
8920495 Mirlay Dec 2014 B2
8945213 Terwee et al. Feb 2015 B2
8968399 Ghabra Mar 2015 B2
8992611 Zhao Mar 2015 B2
D729390 Doraiswamy et al. May 2015 S
9039760 Brady et al. May 2015 B2
9072600 Tran Jul 2015 B2
9084674 Brady et al. Jul 2015 B2
D738947 Litovchenko Sep 2015 S
9237946 Pynson Jan 2016 B2
9304329 Zhao Apr 2016 B2
9329410 Riall et al. May 2016 B2
9387069 Kahook et al. Jul 2016 B2
9445892 Brown Sep 2016 B2
9554893 Brady et al. Jan 2017 B2
9675445 Moriarty Jun 2017 B2
9757228 Wanders et al. Sep 2017 B2
9820849 Jansen Nov 2017 B2
9848980 McCafferty Dec 2017 B2
9869885 De Sio et al. Jan 2018 B2
9931202 Borja et al. Apr 2018 B2
9937034 Wanders Apr 2018 B2
10004592 Amon Jun 2018 B2
10004596 Brady et al. Jun 2018 B2
10028824 Kahook et al. Jul 2018 B2
20020120329 Lang et al. Aug 2002 A1
20020161436 Portney Oct 2002 A1
20030158560 Portney Aug 2003 A1
20030187504 Weinschenk, III et al. Oct 2003 A1
20030220687 Nordan et al. Nov 2003 A1
20040106993 Portney Jun 2004 A1
20040158322 Shen Aug 2004 A1
20040167621 Peyman Aug 2004 A1
20040249455 Tran Dec 2004 A1
20050027354 Brady et al. Feb 2005 A1
20050060032 Magnante et al. Mar 2005 A1
20050113913 Duvert May 2005 A1
20060001186 Richardson et al. Jan 2006 A1
20060142856 Willis et al. Jun 2006 A1
20060184244 Nguyen et al. Aug 2006 A1
20060241752 Israel Oct 2006 A1
20060253196 Woods Nov 2006 A1
20060265059 Sunada et al. Nov 2006 A1
20070010881 Soye et al. Jan 2007 A1
20070016293 Tran Jan 2007 A1
20070021832 Nordan Jan 2007 A1
20070032866 Portney Feb 2007 A1
20070118216 Pynson May 2007 A1
20070260308 Tran Nov 2007 A1
20070260309 Richardson Nov 2007 A1
20070270947 Peyman Nov 2007 A1
20070282438 Hong et al. Dec 2007 A1
20080046077 Cumming Feb 2008 A1
20080051886 Lin Feb 2008 A1
20080086208 Nordan Apr 2008 A1
20080103592 Maloney May 2008 A1
20080147085 Gardeski et al. Jun 2008 A1
20080208334 Jinkerson et al. Aug 2008 A1
20080208335 Blum Aug 2008 A1
20080215147 Werblin Sep 2008 A1
20080281414 Akahoshi Nov 2008 A1
20080288066 Cumming Nov 2008 A1
20080312738 Wanders Dec 2008 A1
20090048671 Lipshitz et al. Feb 2009 A1
20090062911 Bogaert Mar 2009 A1
20090130176 Bossy-Nobs et al. May 2009 A1
20090182422 Nordan et al. Jul 2009 A1
20090198326 Zhou et al. Aug 2009 A1
20100004742 Cumming Jan 2010 A1
20100016965 Hong et al. Jan 2010 A1
20100036488 de Juan, Jr. et al. Feb 2010 A1
20100094412 Wensrich Apr 2010 A1
20100094413 Rombach et al. Apr 2010 A1
20100161048 Schaper, Jr. Jun 2010 A1
20100161050 Detmers et al. Jun 2010 A1
20100211171 Sarfarazi Aug 2010 A1
20100280609 Simonov et al. Nov 2010 A1
20100292789 Willis et al. Nov 2010 A1
20110021733 Wanders et al. Jan 2011 A1
20110153014 Zhang et al. Jun 2011 A1
20110251686 Masket Oct 2011 A1
20110313520 Shoji et al. Dec 2011 A1
20110313521 Angelopoulos Dec 2011 A1
20110313522 Hayes Dec 2011 A1
20110313523 Hayes Dec 2011 A1
20120109294 Olson May 2012 A1
20120232649 Cuevas Sep 2012 A1
20120253459 Reich et al. Oct 2012 A1
20120323321 Simonov et al. Dec 2012 A1
20130066422 Dworschak et al. Mar 2013 A1
20130110234 DeVita et al. May 2013 A1
20130110235 Schwiegerling May 2013 A1
20130131796 Mirlay May 2013 A1
20130169064 Park et al. Jul 2013 A1
20130190868 Kahook et al. Jul 2013 A1
20130197636 Haefliger Aug 2013 A1
20130204364 Olson Aug 2013 A1
20130238091 Danta et al. Sep 2013 A1
20130253159 Benz et al. Sep 2013 A1
20130304206 Pallikaris et al. Nov 2013 A1
20130317607 Deboer et al. Nov 2013 A1
20130338767 Mazzocchi et al. Dec 2013 A1
20140052246 Kahook et al. Feb 2014 A1
20140121768 Simpson May 2014 A1
20140180404 Tran Jun 2014 A1
20140228949 Argento et al. Aug 2014 A1
20140240657 Pugh et al. Aug 2014 A1
20140243972 Wanders Aug 2014 A1
20140253877 Li et al. Sep 2014 A1
20140277434 Weeber et al. Sep 2014 A1
20140330375 McCafferty Nov 2014 A1
20140330376 Kleinman Nov 2014 A1
20140347624 Ando et al. Nov 2014 A1
20140368789 Webb Dec 2014 A1
20150230981 Kahook et al. Aug 2015 A1
20150297342 Rosen et al. Oct 2015 A1
20160000558 Honigsbaum Jan 2016 A1
20160008126 Salahieh et al. Jan 2016 A1
20160081791 Cady Mar 2016 A1
20160256265 Borja et al. Sep 2016 A1
20160317286 Brady et al. Nov 2016 A1
20160334643 Hyde et al. Nov 2016 A1
20170172733 Scharioth et al. Jun 2017 A1
20170296331 Werblin et al. Oct 2017 A1
Foreign Referenced Citations (84)
Number Date Country
2014202532 Jul 2014 AU
PI1005015 Apr 2013 BR
102012000755 Oct 2013 BR
2717403 Aug 2005 CN
201015617 Feb 2008 CN
203425064 Feb 2014 CN
19501444 Jul 1996 DE
20109306 Aug 2001 DE
10025320 Nov 2001 DE
102007002885 Jul 2008 DE
202010002895 May 2010 DE
202013009162 Nov 2013 DE
0760232 Mar 1997 EP
1369710 Dec 2003 EP
1449498 Aug 2004 EP
1493405 Jan 2005 EP
1504730 Feb 2005 EP
1658828 May 2006 EP
2666735 Mar 1992 FR
2869793 Nov 2005 FR
2966340 Apr 2012 FR
2998474 May 2014 FR
2464505 Apr 2010 GB
2517531 Feb 2015 GB
H07255757 Oct 1995 JP
4199573 Oct 2004 JP
4363573 Nov 2009 JP
4431372 Mar 2010 JP
5398089 Jun 2013 JP
2013528098 Jul 2013 JP
5383782 Jan 2014 JP
2045246 Oct 1995 RU
2080100 Aug 1996 RU
2070004 Dec 1996 RU
2129880 May 1999 RU
2134086 Aug 1999 RU
31954 Sep 2003 RU
2234417 Aug 2004 RU
47696 Sep 2005 RU
2281063 Aug 2006 RU
2281067 Aug 2006 RU
2281726 Aug 2006 RU
2283067 Sep 2006 RU
2288494 Nov 2006 RU
2377964 Jan 2010 RU
2457811 Aug 2012 RU
2479286 Apr 2013 RU
2531472 Oct 2014 RU
M329428 Apr 2008 TW
201103517 Feb 2011 TW
9113597 Sep 1991 WO
9215260 Sep 1992 WO
9407435 Apr 1994 WO
9413225 Jun 1994 WO
9605047 Feb 1996 WO
9712564 Apr 1997 WO
9918457 Apr 1999 WO
9935520 Jul 1999 WO
9956671 Nov 1999 WO
9962434 Dec 1999 WO
0048491 Aug 2000 WO
0108605 Feb 2001 WO
0115635 Mar 2001 WO
0187182 Nov 2001 WO
2005104994 Nov 2005 WO
2006025726 Mar 2006 WO
2006119016 Nov 2006 WO
2007138564 Dec 2007 WO
2008094518 Aug 2008 WO
2010131955 Nov 2010 WO
2011115860 Sep 2011 WO
2013055212 Apr 2013 WO
2013169652 Nov 2013 WO
2014058315 Apr 2014 WO
2014058316 Apr 2014 WO
2014071532 May 2014 WO
2014099338 Jun 2014 WO
2014108100 Jul 2014 WO
2015006839 Jan 2015 WO
2015022514 Feb 2015 WO
2015026226 Feb 2015 WO
2015037994 Mar 2015 WO
2015044235 Apr 2015 WO
2015066502 May 2015 WO
Non-Patent Literature Citations (15)
Entry
Office Action dated Mar. 19, 2020 in connection with U.S. Appl. No. 16/190,959, 81 pages.
“1/1-Designs-Questel”, May 9, 2018, 3 pages.
“1/1-Designs-Questel”, May 9, 2018, 4 pages.
Extended European Search Report and Written Opinion for European Patent Application No. 15845158 dated Mar. 6, 2018, 9 pages.
International Search Report and Written Opinion of the International Searching Authority dated Aug. 30, 2018 in connection with International Patent Application No. PCT/US2018/36519, 13 pages.
International Search Report and Written Opinion of the International Searching Authority dated Dec. 21, 2015 in connection with International Patent Application No. PCT/US2015/051415, 9 pages.
Office Action dated Jun. 24, 2019 in connection with New Zealand Patent Application No. 729994, 3 pages.
Office Action dated Aug. 1, 2019 in connection with Japanese Patent Application No. 2017-535622, 11 pages.
Office Action in connection with Australian Patent Application No. 2019204613 dated Nov. 22, 2019, 3 pages.
Office Action dated May 20, 2020 in connection with Australian Patent Application No. 2018301248, 3 pages.
Office Action dated Jul. 29, 2020 in connection with Australian Patent Application No. 2019204613, 3 pages.
Communication pursuant to Article 94(3) EPC dated Jul. 15, 2020 in connection with European Patent Application No. 15845158.3, 6 pages.
Communication pursuant to Rules 70(2) and 70a(2) EPC dated Nov. 17, 2020 in connection with European Patent Application No. 18831320.9, 1 page.
Supplementary European Search Report dated Oct. 28, 2020 in connection with European Patent Application No. 18831320.9, 7 pages.
Office Action dated Jan. 5, 2021 in connection with Japanese Patent Application No. 2020-066515, 4 pages.
Related Publications (1)
Number Date Country
20190254808 A1 Aug 2019 US
Provisional Applications (1)
Number Date Country
62053771 Sep 2014 US
Continuation in Parts (2)
Number Date Country
Parent 15646254 Jul 2017 US
Child 16398627 US
Parent 14860629 Sep 2015 US
Child 15646254 US